These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24157317)

  • 21. Superoxide dismutase inhibits cytotoxic killing of Fasciola gigantica newly excysted juveniles expressed by sheep invitro.
    Lalrinkima H; Jacob SS; Raina OK; Chandra D; Lalawmpuii K; Lalchhandama C; Behera P; Tolenkhomba TC
    Exp Parasitol; 2022 Nov; 242():108369. PubMed ID: 36058254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Sep; 172(3-4):238-48. PubMed ID: 20627418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the comparative efficacy of a moxidectin plus triclabendazole pour-on solution against adult and immature liver fluke, Fasciola hepatica, in cattle.
    Geurden T; Bartram D; Van Brussel L; Bo L; Scott-Baird E; Rugg D
    Vet Parasitol; 2012 Oct; 189(2-4):227-32. PubMed ID: 22579500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2003 Sep; 91(2):117-29. PubMed ID: 12910417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; McCoy M; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2008 May; 153(1-2):52-64. PubMed ID: 18359570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthelmintic Potential of Thymoquinone and Curcumin on Fasciola gigantica.
    Ullah R; Rehman A; Zafeer MF; Rehman L; Khan YA; Khan MA; Khan SN; Khan AU; Abidi SM
    PLoS One; 2017; 12(2):e0171267. PubMed ID: 28152102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning and characterization of two genes encoding 2-Cys peroxiredoxins from Fasciola gigantica.
    Chaithirayanon K; Sobhon P
    Exp Parasitol; 2010 Jun; 125(2):106-13. PubMed ID: 20093115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy of clorsulon and albendazole against Fasciola hepatica in cattle.
    Kilgore RL; Williams ML; Benz GW; Gross SJ
    Am J Vet Res; 1985 Jul; 46(7):1553-5. PubMed ID: 4026039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newly excysted juveniles (NEJs) of Fasciola gigantica induce mice liver fibrosis and M2 macrophage-like phenotype in vivo.
    Zhang Y; Mei X; Liang Y; Zhu B; Sheng Z; Shi W; Wang D; Huang W
    Microb Pathog; 2020 Feb; 139():103909. PubMed ID: 31805319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tegumental histological effects of Mirazid(®) and myrrh volatile oil on adult Fasciola gigantica.
    Massoud AM; Shalaby HA; El Khateeb RM; Mahmoud MS; Kutkat MA
    Asian Pac J Trop Biomed; 2013 Jun; 3(6):501-4. PubMed ID: 23730566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cloning, characterization and functional analysis of a novel juvenile-specific cathepsin L of Fasciola gigantica.
    Sansri V; Changklungmoa N; Chaichanasak P; Sobhon P; Meemon K
    Acta Trop; 2013 Oct; 128(1):76-84. PubMed ID: 23820262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasciola gigantica: immunolocalization of 28.5 kDa antigen in the tegument of metacercaria and juvenile fluke.
    Anuracpreeda P; Wanichanon C; Sobhon P
    Exp Parasitol; 2009 Jun; 122(2):75-83. PubMed ID: 19303872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of Fasciola gigantica infection using a monoclonal antibody-based sandwich ELISA for detection of circulating cathepsin B3 protease.
    Anuracpreeda P; Chawengkirtikul R; Tinikul Y; Poljaroen J; Chotwiwatthanakun C; Sobhon P
    Acta Trop; 2013 Jul; 127(1):38-45. PubMed ID: 23567552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of flukicides on
    Hasan MM; Roy BC; Biswas H; Rahman M; Anisuzzaman A; Alam MZ; Talukder MH
    Parasitology; 2022 Sep; 149(10):1339-1348. PubMed ID: 35535471
    [No Abstract]   [Full Text] [Related]  

  • 36. Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphenethide.
    Anderson HR; Fairweather I
    Int J Parasitol; 1995 Mar; 25(3):319-33. PubMed ID: 7601590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and humoral responses in liver of cattle and buffaloes infected with a single dose of Fasciola gigantica.
    Molina EC; Skerratt LF
    Vet Parasitol; 2005 Jul; 131(1-2):157-63. PubMed ID: 15936148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of triclabendazole against Fasciola hepatica and Fascioloides magna in naturally infected calves.
    Craig TM; Huey RL
    Am J Vet Res; 1984 Aug; 45(8):1644-5. PubMed ID: 6476577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and differential expression of cathepsin L3 alleles from Fasciola hepatica.
    Zawistowska-Deniziak A; Wasyl K; Norbury LJ; Wesołowska A; Bień J; Grodzik M; Wiśniewski M; Bąska P; Wędrychowicz H
    Mol Biochem Parasitol; 2013 Jul; 190(1):27-37. PubMed ID: 23770026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
    Meaney M; Fairweather I; Brennan GP; Ramasamy P; Subramanian PB
    Parasitol Res; 2002 Apr; 88(4):315-25. PubMed ID: 11999018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.